Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Nipro Corp
5FANipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ products, functional products, dialysis products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products. This business also operates dialysis and training centers. The company's Pharmaceutical-Related business engages in the contract manufacturing of pharmaceutical products with containers for combination products, including injectable kit products consigned by other pharmaceutical companies. The business also provides injectable and oral drugs products. Its PharmaPackaging business offers pharmaceutical packaging containers and glass tubing, such as molded components for vials, syringes, rubber stoppers, and devices used to administer pharmaceuticals; and glass for thermos bottles, lighting and containers for combination products, as well glass for ampoules. It serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan. Address: 3-9-3, Osaka, Japan, 531-8510
Analytics
Zielpreis von Wall Street
224 946.75 JPYKGV
26.8826Dividendenrendite
2.02 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen 5FA
Dividenden-Analyse 5FA
Dividendenwachstum über 5 Jahre
-38 %Kontinuierliches Wachstum
1 JahrAusschüttungsquote 5-Jahres-Durchschnitt
28 %Verlauf der Dividende 5FA
Bewertung der Aktie 5FA
Finanzen 5FA
Ergebnisse | 2019 | Dynamik |